Understanding predisposition to schizophrenia: Toward intervention and prevention

被引:37
作者
Tsuang, MT
Stone, WS
Faraone, SV
机构
[1] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Inst Psychiat Epidemiol & Genet, Boston, MA USA
[3] Psychiat Serv, Brockton West Roxbury VA Med Ctr, Brockton, MA USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[5] Harvard Univ, Inst Psychiat Epidemiol & Genet, Boston, MA USA
[6] Massachusetts Gen Hosp, Psychiat Serv, Boston, MA USA
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2002年 / 47卷 / 06期
关键词
schizophrenia; schizotaxia; genetics; negative symptoms; neuropsychological deficits; schizotaxia treatment protocol;
D O I
10.1177/070674370204700603
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Early intervention to prevent schizophrenia is one of the most important goals of schizophrenia research. However, the field is not yet ready to initiate trials to prevent prodromal or psychotic symptoms in people who are at risk for developing the disorder. In this paper, we consider some of the major obstacles that must be studied before prevention strategies become feasible. Method and Results: One of the most important hurdles is the identification of a syndrome or set of traits that reflects a predisposition to schizophrenia and that might provide potential targets for intervention. In a recent reformulation of Paul Meehl's concept of schizotaxia, we integrate research findings obtained over the last 4 decades to propose a syndrome with meaningful clinical manifestations. We review the conceptualization of this syndrome and consider its multidimensional clinical expression. We then describe preliminary research diagnostic criteria for use in adult, nonpsychotic, first-degree relatives of patients diagnosed with schizophrenia, based on negative symptoms and neuropsychological deficits. We follow this with evidence supporting the validity of the proposed syndrome, which mainly includes social dysfunction and response to a low dosage of one of the newer antipsychotic medications. Conclusions: Continued progress toward the eventual initiation of prevention strategies for schizophrenia will include sustained efforts to validate the traits reflecting a predisposition to develop the disorder (for example, schizotaxia), follow-up studies to confirm initial findings, and the identification of potentially useful preventive interventions.
引用
收藏
页码:518 / 526
页数:9
相关论文
共 82 条
[11]   Abnormalities of brain structure and function in schizophrenia: Implications for aetiology and pathophysiology [J].
Cannon, TD .
ANNALS OF MEDICINE, 1996, 28 (06) :533-539
[12]   RELIABILITIES AND INTERCORRELATIONS OF 8 MEASURES OF PRONENESS TO PSYCHOSIS [J].
CHAPMAN, LJ ;
CHAPMAN, JP ;
MILLER, EN .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1982, 50 (02) :187-195
[13]   Poor P50 suppression among schizophrenia patients and their first-degree biological relatives [J].
Clementz, BA ;
Geyer, MA ;
Braff, DL .
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (12) :1691-1694
[14]  
Cloninger CR, 1998, AM J MED GENET, V81, P275, DOI 10.1002/(SICI)1096-8628(19980710)81:4<275::AID-AJMG1>3.3.CO
[15]  
2-U
[16]  
DEROGATIS LR, 1993, SYMPTOM CHECKLIST 90
[17]   Large CSF volume not attributable to ventricular volume in schizotypal personality disorder [J].
Dickey, CC ;
Shenton, ME ;
Hirayasu, Y ;
Fischer, I ;
Voglmaier, MM ;
Niznikiewicz, MA ;
Seidman, LJ ;
Fraone, S ;
McCarley, RW .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (01) :48-54
[18]   SOCIAL COMPETENCE DEFICITS IN ADOLESCENTS AT RISK FOR SCHIZOPHRENIA [J].
DWORKIN, RH ;
LEWIS, JA ;
CORNBLATT, BA ;
ERLENMEYERKIMLING, L .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1994, 182 (02) :103-108
[19]   Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: The New York high-risk project [J].
Erlenmeyer-Kimling, L ;
Rock, D ;
Roberts, SA ;
Janal, M ;
Kestenbaum, C ;
Cornblatt, B ;
Adamo, UH ;
Gottesman, II .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (09) :1416-1422
[20]  
Erlenmeyer-Kimling L, 2000, AM J MED GENET, V97, P65, DOI 10.1002/(SICI)1096-8628(200021)97:1<65::AID-AJMG9>3.0.CO